The Untitled Podcast is designed to get you to think. Not what to think, but think. We cover subjects in healthtech, medtech, personal performance, and leadership.
Joe Mullings shares expert insights on how OUS medical device companies can successfully navigate the US market by making informed hiring decisions and avoiding common pitfalls.
18 Nov 2024
Acquisitions & Name Changes – What is the Cultural Impact?
Joe Mullings explores the cultural impact of acquisitions and name changes, revealing how high-performing companies often lose their unique identity and native mindset after being acquired.
10 Sept 2024
Resolution Medical – Contract Manufacturing Moving Upstream
Pete Herman of Resolution Medical connected with Joe and Steve Maxson to discuss Resolution’s unique value proposition, especially with reference to their LifeTec Simulation Technology. This tech offers Resolution’s engineering team the opportunity to explore many complex scenarios and gives their customers the opportunity to gain insights from physicians in real time.
10 Sept 2024
Chamfr - A New Pathway in Medtech with Julie Schulte
Julie Schulte joined Joe & Steve Maxson to share more about her company, “the Amazon for medical device”, Chamfr. Chamfr offers a distinctive approach to supply chain the medical device arena. The growth of the platfrom has been tremendous and continues to add features and support for their patrons. Julie’s passion for advancing innovation in medtech is apparent as she looks back on the last 7 years launching Chamfr and to the future.
26 Jul 2024
OUS Robotics Coming to the US with Steve Bell
Joe & Steve Bell discuss surgical robotics, more specifically the companies building a robot outside of the US who have begun the journey to participate in the US market. With many robots in development currently, the road to the US is critical to gaining momentum and market share. The micro and macro differences in how engineers globally approach designing a robot are already coming to light. Differentiators and solving existing problems for surgeons will be key in the race to access the...
26 Jul 2024
Private Equity in Contract Manufacturing
Mike Janish of Vance St Capital joins Joe & Steve Maxson to talk PE in the contract manufacturing world. Knowing how important private money is to funding innovation, Mike and his team are uniquely focused on advancing high-tech medtech and understand the time, effort and resources it takes to make that happen instead of focusing on a quick flip return.
31 May 2024
Contract Manufacturing with Steve Maxon Part 2
Steve and Joe discuss how a career in medtech was not necessarily realized in the CM world. With Provate Equity making transaction in the billions of dollars every year, the new frontier for careers is Contract Manufactuing.
19 May 2024
Contract Manufacturing with Steve Maxon
The Contract Manufacturing sector of the medtech industry is the engine that drives the patient solutions that save lives every day. Steve and Joe discuss how the CM world is part of the new enging of innovation in medtech.
15 May 2024
Robotics Update with Steve Bell
Joe and Steve discuss the rapidly evolving dynamics of the soft tissue surgical robotics markets and what moves some of the current form factors and companies are committing to.
5 Apr 2024
Steve Bell on the Intuitive Da Vinci 5
Intuitive released the DaVinci 5 platform and it is creating a higher bar in the soft tissue surgical robotic market. Joe and Steve discuss how the table stakes for surgical robotics has been leveled up with the D5 platform.
1 Mar 2024
Tony Blauer on Managing Fear in a Career
Tony Blauer wrote the book on the Management of Fear in Combat Sports as well as violent encounters. His body of work is even more applicable in the business world. Joe and Tony discuss how fear management and the control of our emotions can be the difference maker in success and failure.
22 Feb 2024
Steve Bell on Exploring Endovascular Robots and The Market
Steve and Joe discuss the emerging market of endovascular robotics and how it sets up to be a bigger market than soft tissue robotics and enabled by quicker development times, less cost, and more acquirers in the market.
30 Jan 2024
Mike Minogue on Leadership and Abiomed
Joe and Mike Minogue, the recent CEO of Abiomed which was sold to Johnson & Johnson for $16 billion discuss some of the principles and the mindset of how to build high performing teams and enable success.
11 Jan 2024
Soft Tissue Robotics Market with Steve Bell
In the inaugural episode of Joe Mullings Untitled, Steve Bell and Joe Mullings discuss the emerging trends, industry dynamics, the changing centers of care, and where the soft tissue surgical robotic market and technologies are likely going.
Host of Joe Mullings Untitled?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
